Published in J Immunol Res Ther on April 30, 2016
Interferons, immunity and cancer immunoediting. Nat Rev Immunol (2006) 8.23
Graft-versus-leukemia reactions after bone marrow transplantation. Blood (1990) 7.11
Lymphocyte-mediated cytotoxicity. Annu Rev Immunol (2001) 4.37
Graft-versus-host disease. Nat Rev Immunol (2007) 4.26
Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol (2007) 3.65
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity (2007) 3.33
Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity (2007) 2.91
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol (2003) 2.77
Graft-versus-leukemia reactions in allogeneic chimeras. Blood (2003) 1.84
Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease. Blood (2009) 1.57
Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma. Lab Invest (2009) 1.48
Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood (2002) 1.47
Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J Clin Invest (1997) 1.45
Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med (2001) 1.41
Granzymes at a glance. J Cell Sci (2006) 1.18
The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood (1996) 1.13
Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance. Cancer Res (2009) 1.01
A flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunity. PLoS One (2014) 1.00
A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease. J Immunol (2012) 0.89
Granzyme B-mediated damage of CD8+ T cells impairs graft-versus-tumor effect. J Immunol (2012) 0.87
Interferon-Gamma Receptor Signaling Plays an Important Role in Restraining Murine Ovarian Tumor Progression. J Immunol Res Ther (2016) 0.75